These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Stevens-Johnson syndrome and toxic epidermal necrolysis. Harr T; French LE Chem Immunol Allergy; 2012; 97():149-66. PubMed ID: 22613860 [TBL] [Abstract][Full Text] [Related]
23. Stevens Johnson Syndrome with Vaginal Pain and Lesions as Initial Presentation. Mergler R; Chuang M Am J Case Rep; 2018 Dec; 19():1519-1521. PubMed ID: 30573724 [TBL] [Abstract][Full Text] [Related]
24. Allopurinol-Induced Stevens-Johnson Syndrome. Gupta SS; Sabharwal N; Patti R; Kupfer Y Am J Med Sci; 2019 Apr; 357(4):348-351. PubMed ID: 30638600 [TBL] [Abstract][Full Text] [Related]
25. [Toxic epidermal necrolysis: idiosyncratic reaction to drugs]. Rotondaro JC; Kim AC; Monti P; Pazos M; Gazzi C; López R; Riccioppo F; Fadel D Vertex; 2021 Jun; XXXII(152):20-23. PubMed ID: 34783791 [TBL] [Abstract][Full Text] [Related]
27. Stevens-Johnson Syndrome in a Patient on Concomitant Treatment with Levetiracetam and Trimethoprim/Sulfamethoxazole. Tabet Aoul A; Al-Nasseri A; Hall C; He C; Abernathy J Am J Case Rep; 2024 Jan; 25():e942982. PubMed ID: 38247161 [TBL] [Abstract][Full Text] [Related]
28. Patch testing in an unusual case of toxic epidermal necrolysis. Klein CE; Trautmann A; Zillikens D; Bröcker EB Contact Dermatitis; 1995 Dec; 33(6):448-9. PubMed ID: 8706422 [No Abstract] [Full Text] [Related]
29. Effectiveness, safety and tolerability of cyclosporine versus supportive treatment in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A record-based study. Mohanty S; Das A; Ghosh A; Sil A; Gharami RC; Bandyopadhyay D; Das NK Indian J Dermatol Venereol Leprol; 2017; 83(3):312-316. PubMed ID: 28366923 [TBL] [Abstract][Full Text] [Related]
30. A Case of Drug-Induced Stevens-Johnson Syndrome. Lyon DR; Akinboboye O; Jain PV; Jha P WMJ; 2022 Oct; 121(3):E63-E65. PubMed ID: 36301663 [TBL] [Abstract][Full Text] [Related]
31. Stevens-Johnson Syndrome: A Challenging Diagnosis. Davis WD; Schafer PA Adv Emerg Nurs J; 2018; 40(3):176-182. PubMed ID: 30059372 [TBL] [Abstract][Full Text] [Related]
33. [An unusual hemorrhagic variant of Stevens-Johnson syndrome in an HIV-infected patient]. Schmid MH; Elsner P Hautarzt; 1999 Jan; 50(1):52-5. PubMed ID: 10068933 [TBL] [Abstract][Full Text] [Related]
34. Profile and pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a general hospital in Singapore: treatment outcomes. Tan SK; Tay YK Acta Derm Venereol; 2012 Jan; 92(1):62-6. PubMed ID: 21710108 [TBL] [Abstract][Full Text] [Related]
35. Incomplete Stevens-Johnson syndrome secondary to atypical pneumonia. Ramasamy A; Patel C; Conlon C BMJ Case Rep; 2011 Oct; 2011():. PubMed ID: 22679161 [TBL] [Abstract][Full Text] [Related]
36. Concidence of cotrimoxazole induced toxic epidermal necrolysis and chronic Q Fever in an Afghan shepherd. Didona D; Cunha T; Viti G; Juratli HA; Hertl M J Eur Acad Dermatol Venereol; 2022 Nov; 36(11):e939-e940. PubMed ID: 35789041 [No Abstract] [Full Text] [Related]
37. Dermatologic emergencies. Usatine RP; Sandy N Am Fam Physician; 2010 Oct; 82(7):773-80. PubMed ID: 20879700 [TBL] [Abstract][Full Text] [Related]
38. Not All Drugs Are Created Equal: The Importance of Causative Agent in Toxic Epidermal Necrolysis. Cooney R; Beck A; Gonzalez B; Gamelli RL; Mosier MJ J Burn Care Res; 2016; 37(1):e69-78. PubMed ID: 26594865 [TBL] [Abstract][Full Text] [Related]
39. Bullous fixed drug eruption masquerading as recurrent Stevens Johnson syndrome. Dharamsi FM; Michener MD; Dharamsi JW J Emerg Med; 2015 May; 48(5):551-4. PubMed ID: 25433836 [TBL] [Abstract][Full Text] [Related]
40. A review of causes of Stevens-Johnson syndrome and toxic epidermal necrolysis in children. Ferrandiz-Pulido C; Garcia-Patos V Arch Dis Child; 2013 Dec; 98(12):998-1003. PubMed ID: 23873883 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]